Methods and compositions for treating ophthalmic conditions via modulation of megalin activity

Details for Australian Patent Application No. 2007260872 (hide)

Owner SIRiON Therapeutics, Inc

Inventors Han, Yun; Mata, Nathan L.

Agent Griffith Hack

Pub. Number AU-A-2007260872

PCT Pub. Number WO2007/150046

Priority 60/805,586 22.06.06 US

Filing date 22 June 2007

Wipo publication date 27 December 2007

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/150046 Priority application(s): WO2007/150046

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260873-Encapsulated labile compound compositions and methods of making the same

2007260870-Genetic models for stratification of cancer risk